Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-infection is associated
with an extremely variable disease course. When interstitial pneumonia (IP) occurs, it can …

KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with
different interstitial lung diseases, especially in those with a poorer outcome. Given that …

Abstract Background Serum Krebs von den Lungen 6 (KL-6), which reflects alveolar
epithelial injury, was reported to be useful to predict the progression of pneumonitis induced …

Abstract Background Coronavirus disease 2019 (COVID-19) is currently spreading
worldwide. This study examined whether serum Krebs von den Lungen-6 (KL-6) level is a …

Background The global coronavirus disease 2019 (COVID-19) has presented significant
challenges and created concerns worldwide. Besides, patients who have experienced a …

Background: The main target of SARS-CoV2 is the alveolar type II (AT2) cells of the lung.
SARS-CoV2 evades the innate immune system resulting in the release of proinflammatory …

Abstract Background: Krebs von den Lungen 6 (KL-6) is a novel biomarker for interstitial
lung disease, and it reflects acute lung injury. We explored the usefulness of KL-6 to predict …

Severe acute respiratory syndrome coronavirus 2–induced direct cytopathic effects against
type I and II pneumocytes mediate lung damage. Krebs von den Lungen‐6 (KL‐6) is mainly …

The clinical relevance of Krebs von den Lungen-6 (KL-6) levels in patients with coronavirus
disease 2019 (COVID-19) is unclear. This study aimed to evaluate the correlation between …

Background and objectives Krebs von den Lungen-6 (KL-6), expressed by damaged type II
pneumocytes, is useful in the diagnosis and severity assessment of many diffuse interstitial …